Its defining feature is selectivity: unlike earlier GHRPs such as GHRP-2 and GHRP-6, ipamorelin produces minimal effect on cortisol, prolactin, or aldosterone secretion at typical research doses
If GLP-1 medication doses cannot be increased due to side effects, doctors will consider all options for other medications and for optimizing lifestyle, such as nutrition, exercise and sleep, to support the patient's goals
Many clinicians prescribe both together because they activate complementary receptor pathways, producing synergistic GH release greater than either peptide alone
Thats why its important to discuss the risks vs
The exact identity, purity, strength, handling conditions, and storage requirements should be confirmed from the original product documentation.